Randy Hubbell, Armis Biopharma - Decreasing Quantity and Severity of Inflections | LSI USA '24

Armis Biopharma has five approved products that are ready to be commercialized/licensed out in dental, wound care, animal health, disinfectant and a hammer toe implant with an exciting pipeline including a chemical/biologic decontaminate supported by a $20M DoD grant.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach